LPL Financial
PLSE icon

LPL Financial’s Pulse Biosciences PLSE Stock Holding History

LPL Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Hold
9,851
– – ﹤0.01% 5528
2026
Q1 		$213K Buy
+9,851
New +$182K ﹤0.01% 5458
2025
Q4 		– Sell
-12,295
Closed -$218K – 6021
2025
Q3 		$218K Buy
+12,295
New +$195K ﹤0.01% 5291

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

LPL Financial's PLSE Position: Q2 2026 in Review

LPL Financial held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 9,851 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #5528.

LPL Financial first reported a position in PLSE in Q3 2025 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • LPL Financial held 9,851 shares of Pulse Biosciences worth $273K as of Q2 2026.
  • LPL Financial left its Pulse Biosciences share count unchanged in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5528 holding.
  • LPL Financial first reported a position in Pulse Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.